Showing 15 posts of 23 posts found.


The Autumn 2020 edition of Pharmafile is available to read for free online now!

December 1, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing infectious diseases, pharmafile, rare disease, respiratory

The Autumn 2020 edition of Pharmafile is available to read for free online now! 2020 has seen almost unprecedented disruption …


Circassia terminates AstraZeneca partnership in exchange for £150m debt settlement

April 9, 2020
Sales and Marketing AstraZeneca, Circassia, partnership, pharma, respiratory

Circassia Pharmaceuticals has announced its decision to break away from a partnership it forged with AstraZeneca UK back in 2017 …


AZ’s first respiratory biologic meets primary endpoints in Phase III trials

September 5, 2016
Research and Development, Sales and Marketing AstraZeneca, asthma, benralizumab, biologic, respiratory, severe asthma

AstraZeneca has presented Phase III data at the European Respiratory Society (ERS) international congress which shows that trial biologic benralizumab …


GlaxoSmithKline opens new £56 million facility in Hertfordshire

April 19, 2016
Manufacturing and Production Andrew Witty, GSK, GlaxoSmithKline, Sir Andrew Witty, ellipta, facility, george freeman, inhalers, manufacturing, new, respiratory, ware

GlaxoSmithKline has opened a new £56 million manufacturing facility in Hertfordshire, South-East England. The facility in Ware will create 150 …

AstraZeneca to acquire Takeda’s respiratory franchise

December 16, 2015
Manufacturing and Production, Research and Development AstraZeneca, China, Takeda, investment, respiratory

AstraZeneca and Takeda have agreed a multi-million pound deal for AZ to acquire the Japanese firm’s core respiratory business, including …

GSK image

Generics continue to erode GSK sales

May 6, 2015
Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory

GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …

astrazeneca image

AstraZeneca buoyed by late-stage trial success

March 18, 2015
Sales and Marketing AstraZeneca, copd. asthma, formoterol fumarate, glycopyrronium, ptoo3, respiratory

AstraZeneca’s investigational respiratory drug has posted positive results in a Phase III trial in people with COPD, having found it …

AZ image

AstraZeneca completes respiratory deal with Actavis

March 3, 2015
Research and Development, Sales and Marketing Actavis, AstraZeneca, COPD, Daliresp, Tudorza Pressair, aclidinium bromide inhalation powder, respiratory, roflumilast

AstraZeneca has completed its acquisition of Dublin-headquartered firm Actavis with its branded respiratory portfolio deal worth $700 million. The agreement …

Takeda image

Takeda acquires Turkish firm Neutec

February 24, 2015
Sales and Marketing Takeda, Turkey, gastroenterology, neutec, respiratory, turkish

Takeda has signed an agreement to acquire one of Turkey’s leading pharma firms Neutec in a $120 million deal. The …

AZ image

AstraZeneca loses US Pulmicort patent

February 16, 2015
Sales and Marketing AstraZeneca, Budesonide Inhalation Suspension, asthma, pulmicourt, respiratory

British drugmaker AstraZeneca has been dealt a blow by the courts in the US, after a district judge ruled its …

GSK image

GSK confirms hundreds of US job cuts

December 3, 2014
Medical Communications, Research and Development, Sales and Marketing Advair, GSK, Parexel, RTP, anoro, breo, job cuts, respiratory

GlaxoSmithKline has finally confirmed the rumours that it is cutting hundreds of US jobs as the UK firm struggles to …

AstraZeneca completes respiratory deal with Almirall

November 3, 2014
Research and Development, Sales and Marketing Almirall, AstraZeneca, Pfizer, deal, duaklir, merger, respiratory

AstraZeneca has finally completed its takeover of Almirall’s respiratory drug portfolio in a deal worth $875 million. As reported by …

Novartis emphasises pharma growth

June 19, 2014
Sales and Marketing Novartis, breezhaler, dermatology, heart failure, oncology, respiratory

Novartis is to grow its pharma business by focussing on five key areas and predicts that it will have 14 …

Astrazeneca image

AstraZeneca signs respiratory deal

January 29, 2013
Research and Development, Sales and Marketing AstraZeneca, COPD, orexo, respiratory

AstraZeneca has signed a research deal with Swedish pharma company Orexo centred around the development of respiratory disease treatments. For …

AstraZeneca signs respiratory pact with Amgen

April 5, 2012
Research and Development Amgen, AstraZeneca, MedImmune, respiratory

AstraZeneca has bought its way into Amgen’s inflammation portfolio with a $50 million upfront payment to co-develop and commercialise five …

Latest content